Pfiz­er chal­lenges Mod­er­na Covid vac­cine patents be­fore Patent Tri­al and Ap­peal Board

Pfiz­er is chal­leng­ing the Covid-19 vac­cine patents that Mod­er­na has ac­cused the com­pa­ny of in­fring­ing be­fore the Patent Tri­al and Ap­peal Board (PT­AB), ar­gu­ing that the patents are too broad and hinge on in­for­ma­tion about mR­NA that was known well be­fore the de­vel­op­ment of the vac­cines.

Pfiz­er and BioN­Tech ar­gue in two sep­a­rate pe­ti­tions for in­ter partes re­view filed with the PT­AB Mon­day that Mod­er­na is at­tempt­ing to “coopt an en­tire field of mR­NA tech­nol­o­gy.” The PT­AB chal­lenges re­late to the law­suit Mod­er­na brought against Pfiz­er and BioN­Tech in Au­gust 2022, al­leg­ing that their vac­cine Comir­naty copied Mod­er­na’s vac­cine tech­nol­o­gy, which was patent­ed be­fore the pan­dem­ic when Mod­er­na was de­vel­op­ing an­oth­er mR­NA vac­cine for MERS.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER